News
09-07-2013, 12:30 AM
The U.S. Food and Drug Administration today expanded the approved uses of Abraxane (paclitaxel protein-bound particles for injectable suspension, ablumin-bound) to treat patients with late-stage (metastatic) pancreatic cancer.
More... (http://www.news-medical.net/news/20130907/FDA-approves-use-of-abraxane-to-treat-patients-with-late-stage-pancreatic-cancer.aspx)
More... (http://www.news-medical.net/news/20130907/FDA-approves-use-of-abraxane-to-treat-patients-with-late-stage-pancreatic-cancer.aspx)